|
Status |
Public on Feb 13, 2019 |
Title |
IFN-α-producing proliferating myeloid cells reveal type I IFN-stimulating gene signature |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
We previously established a method to generate myeloid lineage cells with proliferation capacity from induced pluripotent stem cells (iPSCs) (Zhang R. Cancer Immunol Res. 3: 668, 2015). In this study, we generated the IFN-α-producing cells by genetic engineering of mouse iPSC-derived myeloid cells (iPSC-pMCs). Gene expression profiling of IFN-α-producing iPSC-pMCs (IFN-α-iPSC-pMCs) revealed a distinct interferon-stimulated gene (ISG) signature: of 613 differentially expressed genes (versus iPSC-pMC), 345 genes were ISGs of which > 70 % were type I IFN-related. Gene ontology analysis showed that the up-regulated gene signature was enriched for transcripts associate with immune responses, cellular responses to type I IFN, and defense responses to virus.
|
|
|
Overall design |
Gene expression profiles of iPSC-pMCs, IFN-α-transuduced iPSC-pMCs, and IFN-α-treated iPSC-pMCs.
|
|
|
Contributor(s) |
Uemura Y, Zhang R |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Feb 08, 2019 |
Last update date |
Mar 21, 2019 |
Contact name |
Ranmaru Shimoda |
E-mail(s) |
shimoda@rhelixa.com
|
Phone |
+818043368250
|
Organization name |
Rhelixa, Inc.
|
Street address |
3F Yayoi Bldg., 3-7-4 Iwamotocho
|
City |
Chiyoda |
State/province |
Tokyo |
ZIP/Postal code |
101-0032 |
Country |
Japan |
|
|
Platforms (1) |
GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
Samples (6)
|
|
This SubSeries is part of SuperSeries: |
GSE126281 |
Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells |
|
Relations |
BioProject |
PRJNA521844 |
SRA |
SRP185724 |